IP Watchdog

AUGUST 18, 2022

Court of Appeals for the Federal Circuit (CAFC) today affirmed a district court’s finding that Eagle Pharmaceuticals, Inc.’s s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par).

Patent 72

Patent Patent Infringement Litigation Intellectual Property 72

Technology & Marketing Law Blog

MAY 30, 2023

The case involves Vital Pharmaceuticals, which markets “performance energy drinks” a/k/a drinks that accelerate your death. Its flagship product is Bang , which might have been a sexual allusion but now is an apt description of the company’s fate. The company fired its CEO, Mr. Owoc, and is now in Chapter 11.

Social Media 79

Social Media Ownership Marketing Marketing 79

SpicyIP

FEBRUARY 26, 2024

Highlights of the Week ‘Non’-Pharmaceutical Substance and Efficacy under Sec 3(d) Image from here Can Section 3(d) be applied to a non pharmaceutical invention? Kevin discusses his thoughts on the ability of High Courts to hear rectification petitions in light of the recent DHC order in Hershey Company vs Dilip Kumar Bacha.

Trademark 59

Trademark Copyright Registration Designs 59